Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2006-01-17
2006-01-17
Hui, San-Ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
Reexamination Certificate
active
06987100
ABSTRACT:
Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both of an effect of suppressing bone resorption accompanying multiple myeloma and an effect of inhibiting multiple myeloma, more particularly, 1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-bisphosphonic acid or its salt.
REFERENCES:
patent: 4990503 (1991-02-01), Isomura et al.
patent: 0 647 649 (1995-04-01), None
patent: WO 95/28936 (1995-11-01), None
patent: WO 99/04773 (1999-02-01), None
Kunzmann et al,Blood, 92(10, Suppl. 1, Part 1-2):279B (1998).
Berenson,Cancer, 80(8, Supplement):1661-1667 (1997).
Shipman et al,British Journal of Haematology, 98:6565-672 (1997).
Roux et al,Bone, 15(1):41-49 (1994).
Shipman et al,Leukemia and Lymphoma, 32)1-2):129-138 (1998).
Dhodapkar et al,British Journal of Haematology, 103:530-532 (1998).
Asano Hironobu
Matsukawa Utane
Tanaka Shohei
Astellas Pharm Inc.
Hui San-Ming
LandOfFree
Pharmaceutical compositions for treating bone lesions in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions for treating bone lesions in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for treating bone lesions in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3598529